
Sign up to save your podcasts
Or


What happens when patients become true partners in healthcare innovation? In this episode of Moving Medicine Forward, we speak with Dr. Karin Hehenberger, physician, scientist, transplant recipient, and Founder & President of Lyfebulb, about how lived experience can reshape chronic disease care.
Diagnosed with type 1 diabetes as a teenager, Karin’s journey through medicine, biotech, and ultimately organ transplantation inspired Lyfebulb’s mission to empower patients through education, community, and innovation. We explore why patient voices must be included early in development, how patient entrepreneurs are driving real‑world solutions, and why reducing isolation is essential to better outcomes.
01:00 Welcome & Guest IntroductionMeet Dr. Karin Hehenberger and the mission behind Lyfebulb.
02:10 Living With Chronic Illness Karin’s early diabetes diagnosis and how it shaped her path into medicine and research.
05:35 When Disease Progresses Anyway Facing kidney failure and vision loss despite careful disease management.
06:45 Transplant & New Perspective How kidney and pancreas transplants led to a renewed purpose.
07:55 Founding Lyfebulb Why patient education, connection, and innovation are central to empowerment.
10:45 Patients as Partners Moving beyond “patient‑centric” language to true collaboration.
12:20 Patient‑Driven Innovation Innovation challenges and real solutions created by patients for patients.
17:55 The Power of Community Reducing isolation to improve emotional health and daily disease management.
22:45 Industry & Research CollaborationWhy patient insight must be integrated early—not as a checkbox.
27:15 Rethinking Chronic Disease A vision for managing chronic illness without constant mental burden.
31:15 Learn More How to get involved at LyfeBulb.comb
By CTI Clinical TrialsWhat happens when patients become true partners in healthcare innovation? In this episode of Moving Medicine Forward, we speak with Dr. Karin Hehenberger, physician, scientist, transplant recipient, and Founder & President of Lyfebulb, about how lived experience can reshape chronic disease care.
Diagnosed with type 1 diabetes as a teenager, Karin’s journey through medicine, biotech, and ultimately organ transplantation inspired Lyfebulb’s mission to empower patients through education, community, and innovation. We explore why patient voices must be included early in development, how patient entrepreneurs are driving real‑world solutions, and why reducing isolation is essential to better outcomes.
01:00 Welcome & Guest IntroductionMeet Dr. Karin Hehenberger and the mission behind Lyfebulb.
02:10 Living With Chronic Illness Karin’s early diabetes diagnosis and how it shaped her path into medicine and research.
05:35 When Disease Progresses Anyway Facing kidney failure and vision loss despite careful disease management.
06:45 Transplant & New Perspective How kidney and pancreas transplants led to a renewed purpose.
07:55 Founding Lyfebulb Why patient education, connection, and innovation are central to empowerment.
10:45 Patients as Partners Moving beyond “patient‑centric” language to true collaboration.
12:20 Patient‑Driven Innovation Innovation challenges and real solutions created by patients for patients.
17:55 The Power of Community Reducing isolation to improve emotional health and daily disease management.
22:45 Industry & Research CollaborationWhy patient insight must be integrated early—not as a checkbox.
27:15 Rethinking Chronic Disease A vision for managing chronic illness without constant mental burden.
31:15 Learn More How to get involved at LyfeBulb.comb